Search
for
Sort by
Research 121–150 of 1000+
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- Alopecia Areata: An Update on Treatment Options for Children
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible
- Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Follicular Vitiligo: A Rare and Under Recognized Variant
- Hair today, gone tomorrow
- Resident Memory T Cells in Autoimmune Skin Diseases
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Drug news and therapeutic news
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Topical tofacitinib in treatment of alopecia areata
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report
- Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Evidence for the off-label use of tofacitinib in alopecia areata
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy